Practical usage of ciclosporin 0.09% for moderate-severe dry eye disease
Date: 20/03/2024 (AEDT)
Venue: QT Hotel, 49 Market Street, Sydney, NSW, 2000
Provider: Sun Pharma ANZ
Contact: Sarah Kim, [E] sarah.kim@sunpharma.com, [P] 0426788600
CPD Activity Outline
Join our interactive educational dinner event where Margaret Lam (National President Optometry Australia, National Vice President Cornea and Contact Lens Society) will explore the role of ciclosporin 0.09% in the management of moderate to severe dry eye disease and discuss the practical considerations with its usage, including prescribing, patient selection and patient education.
Real-life application of how ciclosporin 0.09% has been utilised in clinical practice for best patient outcomes will also be presented through case studies and optometrists will have an opportunity to participate in small group interactive discussions on specific examples/case studies and share their management plan and learnings to the wider group.
Register Here: Practical usage of ciclosporin 0.09% for moderate-severe dry eye disease
Learning Objectives
- Understand why treating underlying inflammation is important in moderate-severe dry eye disease for long term disease management
- Understand the role of ciclosporin 0.09% in the management of moderate-severe dry eye disease
- Develop a deeper understanding of the practical considerations in ciclosporin 0.09% management therapy including patient education, prescribing and expectations
- Understand how to utilise ciclosporin 0.09% for moderate-severe dry eye disease in clinical practice for best patient outcomes
Max CPD hours awarded: 2.5
Session Information
| Name |
|---|
| Practical use of ciclosporin 0.09% in moderate-severe dry eye disease |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 2.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 2.5 |